학술논문

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
Document Type
Article
Source
In Blood Advances 28 March 2023 7(6):1056-1064
Subject
Immunobiology and Immunotherapy
Lymphoid Neoplasia
Language
ISSN
2473-9529